BioScience Health Innovations, Inc. (BHIC) Financial Statements (2026 and earlier)

Company Profile

Business Address 2722 S WEST TEMPLE
SALT LAKE CITY, UT 84115
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 7374 - Computer Processing and Data Preparation and Processing Services (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
8/31/2022
8/31/2021
8/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6626631916221
Cash and cash equivalent6626631916221
Receivables53712236   
Inventory, net of allowances, customer advances and progress billings3365838   
Inventory3365838   
Prepaid expense215  4 
Other undisclosed current assets2     
Total current assets:1,5598489316621
Noncurrent Assets
Operating lease, right-of-use asset61     
Intangible asset, including goodwill, after accumulated amortization8326    
Intangible asset, excluding goodwill, after accumulated amortization8326    
Deposits noncurrent assets4     
Total noncurrent assets:14926    
TOTAL ASSETS:1,7078749316621
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14149207
Interest and dividends payable✕✕✕✕✕0 
Accounts payable6882 7
Accrued liabilities861   
Deferred revenue137244   
Debt    9 
Due to related parties✕✕✕✕ 31
Total current liabilities:15139132128
Noncurrent Liabilities
Other undisclosed liabilities79 87 7 
Total liabilities:230391002198
Equity
Equity, attributable to parent1,477835(7)14(13)13
Preferred stock0000  
Common stock144111
Additional paid in capital1,1751,1724171312121
Retained earnings (accumulated deficit)301(341)(428)(117)(34)(9)
Total equity:1,477835(7)14(13)13
TOTAL LIABILITIES AND EQUITY:1,7078749316621

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
8/31/2022
8/31/2021
8/31/2020
Revenues5,6891,845598   
Cost of revenue
(Cost of Product and Service Sold)
(2,448)(536)(113)   
Gross profit:3,2411,309484   
Operating expenses(2,522)(1,222)(736)(92)(26)(8)
Operating income (loss):71987(252)(92)(26)(8)
Nonoperating income
(Other Nonoperating income)
    9  
Interest and debt expense    9(0) 
Income (loss) from continuing operations before equity method investments, income taxes:71987(252)(74)(26)(8)
Other undisclosed loss from continuing operations before income taxes    (9)  
Income (loss) from continuing operations before income taxes:71987(252)(83)(26)(8)
Income tax expense (77)     
Other undisclosed loss from continuing operations      
Income (loss) from continuing operations:64287(252)(83)(26)(8)
Loss before gain (loss) on sale of properties:✕✕✕✕(83)(26)(8)
Net income (loss):64287(252)(83)(26)(8)
Other undisclosed net income attributable to parent     0 
Net income (loss) available to common stockholders, diluted:64287(252)(83)(26)(8)

Comprehensive Income ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
8/31/2022
8/31/2021
8/31/2020
Net income (loss):64287(252)(83)(26)(8)
Comprehensive income (loss), net of tax, attributable to parent:64287(252)(83)(26)(8)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: